A structure-based macrocyclic inhibitor of peptide deformylase showed antibacterial activity through a novel mechanism — blocking an essential bacterial protein processing enzyme with no human equivalent.
No human equivalentThe target enzyme (peptide deformylase) exists in bacteria but NOT humans — ensuring antibiotics targeting it are inherently selective with minimal human side effects
What the researchers found
A structure-based macrocyclic peptide deformylase inhibitor showed potent enzyme inhibition with a novel antibiotic mechanism targeting an essential bacterial enzyme absent in humans.
Why it matters
Peptide deformylase is a validated antibiotic target with no human equivalent, ensuring selectivity. Macrocyclic inhibitors achieve potent binding through conformational restriction.
How the study worked
Structure-based drug design using crystal structure of peptide deformylase. Macrocyclic inhibitor designed by cross-linking P1' and P3' side chains. Enzyme inhibition measured in vitro.
What this study cannot tell us
Short abstract with limited potency and selectivity data. In-vivo antibacterial efficacy not demonstrated.
How to read the evidence
Preliminary in-vitro evidence from structure-based design with enzyme inhibition data.
When this study was published
Published in 2003. Peptide deformylase inhibitors have been further developed as a novel antibiotic class.
The bigger picture
Novel antibiotic mechanisms are desperately needed. Peptide deformylase inhibition is inherently bacteria-selective (humans lack the enzyme), and macrocyclic design improves drug properties.
Questions still open
- Can this achieve in-vivo antibacterial efficacy?
- What is the antibacterial spectrum?
- Could resistance develop through deformylase mutations?
Common questions
Why target an enzyme only bacteria have?
Is this a new type of antibiotic?
Read the original research
Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Journal of medicinal chemistry, 46(18), 3771-4
Citation
Hu, Xubo; Nguyen, Kiet T; Verlinde, Christophe L M J; Hol, Wim G J; Pei, Dehua. (2003). Structure-based design of a macrocyclic inhibitor for peptide deformylase.. Journal of medicinal chemistry, 46(18), 3771-4.